Sign In
Buy RMBL
$3.71
+0 (+0%)
At Close: Jan 16, 2026
Wall Street Analysts Predict a 52.1% Upside in RumbleON, Inc. (RMBL): Here's What You Should Know
11:26am, Monday, 15'th May 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 52.1% in RumbleON, Inc. (RMBL). While the effectiveness of this highly sought-after metric is questionable, the
RumbleON, Inc. (RMBL) Q1 2023 Earnings Call Transcript
06:30pm, Wednesday, 10'th May 2023
RumbleON, Inc. (NASDAQ:RMBL ) Q1 2023 Results Conference Call May 10, 2023 8:30 AM ET Company Participants Will Newell - Head, IR Marshall Chesrown - Chairman, CEO Blake Lawson - CFO Conference Call P
RumbleON, Inc. (RMBL) Q1 Earnings and Revenues Surpass Estimates
09:55am, Wednesday, 10'th May 2023
RumbleON, Inc. (RMBL) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.33 per share. This compares to earnings of $0.58 per share a year ago.
RumbleOn Announces First Quarter 2023 Earnings Release and Conference Call Schedule
07:30am, Wednesday, 26'th Apr 2023
IRVING, Texas--(BUSINESS WIRE)--RumbleOn, Inc. (NASDAQ: RMBL) (the “Company” or “RumbleOn”), the nation's first technology-based omnichannel powersports platform, today announced that it will
Trump-related stocks surge after indictment
08:59am, Friday, 31'st Mar 2023
Three stocks with ties to former President Donald Trump surged Friday after two sources familiar with the case told CNN that Trump faces 30 counts related to business fraud in an indictment from a Man
RumbleON, Inc. (RMBL) Fourth Quarter and Full Year 2022 Earnings Conference Call Transcript
03:26pm, Thursday, 16'th Mar 2023
RumbleON, Inc. (NASDAQ:RMBL ) Fourth Quarter and Full Year 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants William Newell - Investor Relations Marshall Chesrown - Chairman
RumbleON, Inc. (RMBL) Reports Q4 Loss, Misses Revenue Estimates
11:28am, Thursday, 16'th Mar 2023
RumbleON, Inc. (RMBL) delivered earnings and revenue surprises of -655.56% and 6.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
RumbleOn to Present at the D.A. Davidson 6th Annual Consumer Growth Conference
07:30am, Tuesday, 14'th Mar 2023
IRVING, Texas--(BUSINESS WIRE)--RumbleOn, Inc. (NASDAQ: RMBL) (the “Company” or “RumbleOn”), the nation's first technology-based omnichannel powersports platform, today announced that Marshall
RumbleOn to Present at the 25th ICR Conference on January 9, 2023
07:30am, Tuesday, 03'rd Jan 2023
IRVING, Texas--( BUSINESS WIRE )--RumbleOn, Inc. (NASDAQ: RMBL) (the “Company” or “RumbleOn”), the nation's first technology-based omnichannel powersports platform, today announced that Marsha
RumbleON: Skeptical In The Short-Run But Optimistic In The Long-Run
02:26am, Thursday, 01'st Dec 2022
The company's stock price has dropped more than 79% in the past year, lagging the industry average by 64%. Its thin profit margins, weak cash flows, and weak balance sheet are to blame for the falling
RumbleOn to Present at the Wolfe Research Consumer Growth Conference on December 6, 2022
07:24am, Tuesday, 29'th Nov 2022
IRVING, Texas--( BUSINESS WIRE )--RumbleOn, Inc. (NASDAQ: RMBL) (the “Company” or “RumbleOn”), the nation's first technology-based omnichannel powersports platform, announced today that it wil
RumbleON, Inc. (RMBL) Q3 2022 Earnings Call Transcript
03:27pm, Saturday, 12'th Nov 2022
RumbleON, Inc. (NASDAQ:RMBL ) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ET Company Participants Will Newell - IR Marshall Chesrown - Chairman & CEO Narinder Sahai - CFO Conference Call
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
10:12am, Thursday, 10'th Nov 2022 Benzinga
Gainers
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares climbed 212.8% to close at $12.51 on Wednesday after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimac
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
05:33pm, Wednesday, 09'th Nov 2022 Benzinga
Gainers
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares jumped 219% to $12.80 after partner Ipsen reported Onivyde met its primary and key secondary endpoint. Merrimack is eligible for up to $
RumbleON, Inc. (RMBL) Q3 Earnings Lag Estimates
01:45pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
RumbleON, Inc. (RMBL) delivered earnings and revenue surprises of -28.95% and 2.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
